These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6667217)

  • 41. [Chronobiological study of the urinary excretion of delta-aminolevulinic acid in man].
    Botta A; Bruguerolle B; Bartolin R; Bouvenot G
    Rev Med Interne; 1986 Sep; 7(4):421-4. PubMed ID: 3797874
    [No Abstract]   [Full Text] [Related]  

  • 42. Relationships between three indicators of lead exposure in workers: blood lead, delta-aminolevulinic acid and free erythrocyte protoporphyrin.
    Labrèche F; P'an A
    Int Arch Occup Environ Health; 1982; 51(1):35-44. PubMed ID: 7152700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Blood, urine and water levels of lead and cadmium and urinary delta-aminolevulinic acid levels].
    Roosels D; Bossiroy JM
    Arch Belg Med Soc; 1978 May; 36(5):269-82. PubMed ID: 736552
    [No Abstract]   [Full Text] [Related]  

  • 44. [Biochemical study of various occupational groups exposed to lead].
    Kutter D; Machoud M
    Bull Soc Sci Med Grand Duche Luxemb; 1978; 115(1):35-41. PubMed ID: 699239
    [No Abstract]   [Full Text] [Related]  

  • 45. [Use of cathionite Q-2 instead of Dauex-50 as a method of determination of delta-aminolevulinic acid in urine].
    Liubchenko PN; Lapshina IM; Teterin VA; Demidenko NS
    Lab Delo; 1976; (2):90-2. PubMed ID: 58108
    [No Abstract]   [Full Text] [Related]  

  • 46. Species difference of urinary excretion of delta-aminolevulinic acid and coproporphyrin in mice and rats exposed to lead.
    Tomokuni K; Ichiba M; Hirai Y
    Toxicol Lett; 1988 Jun; 41(3):255-9. PubMed ID: 3376152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors affecting determination of delta-aminolevulinate by use of Ehrlich's reagent.
    Tomokuni K; Hirai Y
    Clin Chem; 1986 Jan; 32(1 Pt 1):192-3. PubMed ID: 3940706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluorimetric determination of urinary delta-aminolevulinic acid by high-performance liquid chromatography and post-column derivatization.
    Okayama A
    J Chromatogr; 1988 Apr; 426(2):365-9. PubMed ID: 3392148
    [No Abstract]   [Full Text] [Related]  

  • 49. [Behavior of deltaaminolevulinic acid concentration in urine and various hematologic parameters in lead-exposed subjects].
    Heinemann G
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl; 1980 Mar; 30(3):70-4. PubMed ID: 7467900
    [No Abstract]   [Full Text] [Related]  

  • 50. Specific gravity adjustment for urinary analysis of delta-aminolevulinic acid.
    Ong CN; Lee BL; Foo SC; Ong HY; Chua LH
    Am Ind Hyg Assoc J; 1985 Aug; 46(8):B10, B12. PubMed ID: 4050675
    [No Abstract]   [Full Text] [Related]  

  • 51. Optimized fluorometric determination of urinary delta-aminolevulinic acid by using pre-column derivatization, and identification of the derivative.
    Okayama A; Fujii S; Miura R
    Clin Chem; 1990 Aug; 36(8 Pt 1):1494-7. PubMed ID: 2103726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of blood lead values from blood porphyrin and urinary 5-aminolevulinic acid levels in workers.
    Herber RF
    Int Arch Occup Environ Health; 1980 Feb; 45(2):169-79. PubMed ID: 7364493
    [No Abstract]   [Full Text] [Related]  

  • 53. [Biological monitoring of workers exposed to lead. Usefulness and limitations of indicators of internal dose and early biological effect].
    Alessio L; Bertazzi PA; Cortona G
    Med Lav; 1978; 69(1):4-25. PubMed ID: 349336
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of urea on the simple determination of delta-aminolevulinic acid in urine.
    Tomokuni K; Hirai Y
    Ind Health; 1985; 23(4):295-7. PubMed ID: 3833861
    [No Abstract]   [Full Text] [Related]  

  • 55. Urinary delta-aminolevulinic acid (ALA) levels in lead poisoning. II. Correlation of ALA values with clinical findings in 250 children with suspected lead ingestion.
    Davis JR; Abrahams RH; Fishbein WI; Fabrega EA
    Arch Environ Health; 1968 Aug; 17(2):164-71. PubMed ID: 5672531
    [No Abstract]   [Full Text] [Related]  

  • 56. Urinary excretion of delta aminolevulinic acid after discontinuance of therapy for lead poisoning. A test for adequacy of therapy.
    Vitale LF; Fine BP; Barth A; Filkin K
    J Pediatr; 1972 Nov; 81(5):977-9. PubMed ID: 4628755
    [No Abstract]   [Full Text] [Related]  

  • 57. [Lead exposure of selected population groups. II. The lead level of the blood and delta-aminolevulinic acid level of the urine in the workers in a modern lead and zinc plant].
    Grabecki J; Jarkowski M; Michalewicz L
    Rocz Panstw Zakl Hig; 1981; 32(5-6):439-47. PubMed ID: 7344057
    [No Abstract]   [Full Text] [Related]  

  • 58. Creatinine and specific gravity adjustment of ALA in urinary spot samples: is there any need?
    Dell'Orto A; Berlin A; Toffoletto F; Losito B; Alessio L
    Am Ind Hyg Assoc J; 1987 May; 48(5):A331-2. PubMed ID: 3591657
    [No Abstract]   [Full Text] [Related]  

  • 59. The unsuitability of random urinary delta aminolevulinic acid samples as a screening test for lead poisoning.
    Specter MJ; Guinee VF; Davidow B
    J Pediatr; 1971 Nov; 79(5):799-804. PubMed ID: 5116703
    [No Abstract]   [Full Text] [Related]  

  • 60. [Renal delta-aminolevulinic acid excretion in persons not exposed to lead].
    Massmann W
    Zentralbl Arbeitsmed Arbeitsschutz Prophyl Ergonomie; 1982 Jun; 32(6):210-2. PubMed ID: 7113496
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.